6 research outputs found
Use of Soft Heterocyclic NāDonor Ligands To Separate Actinides and Lanthanides
The removal of the most long-lived radiotoxic elements
from used
nuclear fuel, minor actinides, is foreseen as an essential step toward
increasing the public acceptance of nuclear energy as a key component
of a low-carbon energy future. Once removed from the remaining used
fuel, these elements can be used as fuel in their own right in fast
reactors or converted into shorter-lived or stable elements by transmutation
prior to geological disposal. The SANEX process is proposed to carry
out this selective separation by solvent extraction. Recent efforts
to develop reagents capable of separating the radioactive minor actinides
from lanthanides as part of a future strategy for the management and
reprocessing of used nuclear fuel are reviewed. The current strategies
for the reprocessing of PUREX raffinate are summarized, and some guiding
principles for the design of actinide-selective reagents are defined.
The development and testing of different classes of solvent extraction
reagent are then summarized, covering some of the earliest ligand
designs right through to the current reagents of choice, bisĀ(1,2,4-triazine)
ligands. Finally, we summarize research aimed at developing a fundamental
understanding of the underlying reasons for the excellent extraction
capabilities and high actinide/lanthanide selectivities shown by this
class of ligands and our recent efforts to immobilize these reagents
onto solid phases
Synthesis and Screening of Modified 6,6ā²-Bis(5,5,8,8-tetramethyl-5,6,7,8-tetrahydrobenzo[<i>e</i>][1,2,4]triazin-3-yl)-2,2ā²-bipyridine Ligands for Actinide and Lanthanide Separation in Nuclear Waste Treatment
Effects of chloro and bromo substitution
at the 4-position of the pyridine ring of 6,6ā²-bisĀ(5,5,8,8-tetramethyl-5,6,7,8-tetrahydrobenzoĀ[<i>e</i>]Ā[1,2,4]Ātriazin-3-yl)-2,2ā²-bipyridine (CyMe<sub>4</sub>-BTBP) have been studied with regard to the extraction of
AmĀ(III) from EuĀ(III) and CmĀ(III) from 0.1ā3 M HNO<sub>3</sub>. Similarly to CyMe<sub>4</sub>-BTBP, a highly efficient (<i>D</i><sub>Am</sub> > 10 at 3 M HNO<sub>3</sub>) and selective
(SF<sub>Am/Eu</sub> > 100 at 3 M HNO<sub>3</sub>) extraction was
observed for Cl-CyMe<sub>4</sub>-BTBP and Br-CyMe<sub>4</sub>-BTBP
in 1-octanol but in the absence of a phase-transfer agent
Lanthanide Speciation in Potential SANEX and GANEX Actinide/Lanthanide Separations Using Tetra-N-Donor Extractants
LanthanideĀ(III)
complexes with N-donor extractants, which exhibit the potential for
the separation of minor actinides from lanthanides in the management
of spent nuclear fuel, have been directly synthesized and characterized
in both solution and solid states. Crystal structures of the Pr<sup>3+</sup>, Eu<sup>3+</sup>, Tb<sup>3+</sup>, and Yb<sup>3+</sup> complexes
of 2,9-bisĀ(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-1,2,4-benzotriazin-3-yl)-1,10-phenanthroline
(CyMe<sub>4</sub>-BTPhen) and the Pr<sup>3+</sup>, Eu<sup>3+</sup>, and Tb<sup>3+</sup> complexes of 6,6ā²-bisĀ(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-1,2,4-benzotriazin-3-yl)-2,2ā²-bypyridine
(CyMe<sub>4</sub>-BTBP) were obtained. The majority of these structures
displayed coordination of two of the tetra-N-donor ligands to each
Ln<sup>3+</sup> ion, even when in some cases the complexations were
performed with equimolar amounts of lanthanide and N-donor ligand.
The structures showed that generally the lighter lanthanides had their
coordination spheres completed by a bidentate nitrate ion, giving
a 2+ charged complex cation, whereas the structures of the heavier
lanthanides displayed tricationic complex species with a single water
molecule completing their coordination environments. Electronic absorption
spectroscopic titrations showed formation of the 1:2 Ln<sup>3+</sup>/L<sub>N<sub>4</sub>ādonor</sub> species (Ln = Pr<sup>3+</sup>, Eu<sup>3+</sup>, Tb<sup>3+</sup>) in methanol when the N-donor
ligand was in excess. When the Ln<sup>3+</sup> ion was in excess,
evidence for formation of a 1:1 Ln<sup>3+</sup>/L<sub>N<sub>4</sub>ādonor</sub> complex species was observed. Luminescent lifetime
studies of mixtures of Eu<sup>3+</sup> with excess CyMe<sub>4</sub>-BTBP and CyMe<sub>4</sub>-BTPhen in methanol indicated that the
nitrate-coordinated species is dominant in solution. X-ray absorption
spectra of Eu<sup>3+</sup> and Tb<sup>3+</sup> species, formed by
extraction from an acidic aqueous phase into an organic solution consisting
of excess N-donor extractant in pure cyclohexanone or 30% tri-<i>n</i>-butyl phosphate (TBP) in cyclohexanone, were obtained.
The presence of TBP in the organic phase did not alter lanthanide
speciation. Extended X-ray absorption fine structure data from these
spectra were fitted using chemical models established by crystallography
and solution spectroscopy and showed the dominant lanthanide species
in the bulk organic phase was a 1:2 Ln<sup>3+</sup>/L<sub>Nādonor</sub> species
BTBPs versus BTPhens: Some Reasons for Their Differences in Properties Concerning the Partitioning of Minor Actinides and the Advantages of BTPhens
Two members of the
tetradentate <i>N</i>-donor ligand families 6,6ā²-bisĀ(1,2,4-triazin-3-yl)-2,2ā²-bipyridine
(BTBP) and 2,9-bisĀ(1,2,4-triazin-3-yl)-1,10-phenanthroline (BTPhen)
currently being developed for separating actinides from lanthanides
have been studied. It has been confirmed that CyMe<sub>4</sub>-BTPhen <b>2</b> has faster complexation kinetics than CyMe<sub>4</sub>-BTBP <b>1</b>. The values for the HOMOāLUMO gap of <b>2</b> are comparable with those of CyMe<sub>4</sub>-BTBP <b>1</b> for which the HOMOāLUMO gap was previously calculated to
be 2.13 eV. The displacement of BTBP from its bis-lanthanumĀ(III) complex
by BTPhen was observed by NMR, and constitutes the only direct evidence
for the greater thermodynamic stability of the complexes of BTPhen.
NMR competition experiments suggest the following order of bis-complex
stability: 1:2 bis-BTPhen complex ā„ heteroleptic BTBP/BTPhen
1:2 bis-complex > 1:2 bis-BTBP complex. Kinetics studies on some
bis-triazine <i>N</i>-donor ligands using the stopped-flow
technique showed a clear relationship between the rates of metal ion
complexation and the degree to which the ligand is preorganized for
metal binding. The BTBPs must overcome a significant (ca. 12 kcal
mol<sup>ā1</sup>) energy barrier to rotation about the central
biaryl CāC axis in order to achieve the <i>cis</i>ā<i>cis</i> conformation that is required to form
a complex, whereas the <i>cis</i>ā<i>cis</i> conformation is fixed in the BTPhens. Complexation thermodynamics
and kinetics studies in acetonitrile show subtle differences between
the thermodynamic stabilities of the complexes formed, with similar
stability constants being found for both ligands. The first crystal
structure of a 1:1 complex of CyMe<sub>4</sub>-BTPhen <b>2</b> with YĀ(NO<sub>3</sub>)<sub>3</sub> is also reported. The metal ion
is 10-coordinate being bonded to the tetradentate ligand <b>2</b> and three bidentate nitrate ions. The tetradentate ligand is nearly
planar with angles between consecutive rings of 16.4(2)Ā°, 6.4(2)Ā°,
9.7(2)Ā°, respectively
BTBPs versus BTPhens: Some Reasons for Their Differences in Properties Concerning the Partitioning of Minor Actinides and the Advantages of BTPhens
Two members of the
tetradentate <i>N</i>-donor ligand families 6,6ā²-bisĀ(1,2,4-triazin-3-yl)-2,2ā²-bipyridine
(BTBP) and 2,9-bisĀ(1,2,4-triazin-3-yl)-1,10-phenanthroline (BTPhen)
currently being developed for separating actinides from lanthanides
have been studied. It has been confirmed that CyMe<sub>4</sub>-BTPhen <b>2</b> has faster complexation kinetics than CyMe<sub>4</sub>-BTBP <b>1</b>. The values for the HOMOāLUMO gap of <b>2</b> are comparable with those of CyMe<sub>4</sub>-BTBP <b>1</b> for which the HOMOāLUMO gap was previously calculated to
be 2.13 eV. The displacement of BTBP from its bis-lanthanumĀ(III) complex
by BTPhen was observed by NMR, and constitutes the only direct evidence
for the greater thermodynamic stability of the complexes of BTPhen.
NMR competition experiments suggest the following order of bis-complex
stability: 1:2 bis-BTPhen complex ā„ heteroleptic BTBP/BTPhen
1:2 bis-complex > 1:2 bis-BTBP complex. Kinetics studies on some
bis-triazine <i>N</i>-donor ligands using the stopped-flow
technique showed a clear relationship between the rates of metal ion
complexation and the degree to which the ligand is preorganized for
metal binding. The BTBPs must overcome a significant (ca. 12 kcal
mol<sup>ā1</sup>) energy barrier to rotation about the central
biaryl CāC axis in order to achieve the <i>cis</i>ā<i>cis</i> conformation that is required to form
a complex, whereas the <i>cis</i>ā<i>cis</i> conformation is fixed in the BTPhens. Complexation thermodynamics
and kinetics studies in acetonitrile show subtle differences between
the thermodynamic stabilities of the complexes formed, with similar
stability constants being found for both ligands. The first crystal
structure of a 1:1 complex of CyMe<sub>4</sub>-BTPhen <b>2</b> with YĀ(NO<sub>3</sub>)<sub>3</sub> is also reported. The metal ion
is 10-coordinate being bonded to the tetradentate ligand <b>2</b> and three bidentate nitrate ions. The tetradentate ligand is nearly
planar with angles between consecutive rings of 16.4(2)Ā°, 6.4(2)Ā°,
9.7(2)Ā°, respectively
New furoquinoline alkaloid and flavanone glycoside derivatives from the leaves of <i>Oricia suaveolens and Oricia renieri</i> (Rutaceae)
<div><p>Fractionation of the methanol extract of the leaves of <i>Oricia renieri</i> and <i>Oricia suaveolens</i> (Rutaceae) led to the isolation of 13 compounds including the hitherto unknown furoquinoline alkaloid named 6,7-methylenedioxy-5-hydroxy-8-methoxy-dictamnine <b>(1)</b> and a flavanone glycoside named 5-hydroxy-4ā²-methoxy-7-<i>O</i>-[Ī±-l-rhamnopyranosyl(1ā“ā5ā³)-Ī²-d-apiofuranosyl]-flavanoside <b>(2)</b>, together with 11 known compounds <b>(3</b>ā<b>13)</b>. The structures of the compounds were determined by comprehensive analyses of their 1D and 2D NMR, mass spectral data and comparison. All compounds isolated were examined for their activity against human carcinoma cell lines. The alkaloids <b>1</b>, <b>5</b>, <b>12</b>, <b>13</b> and the phenolic <b>2</b>, <b>8</b>, <b>11</b> tested compounds exhibited non-selective moderate cytotoxic activity with IC<sub>50</sub> 8.7ā15.9Ā Ī¼M whereas compounds <b>3</b>, <b>4</b>, <b>6</b>, <b>7</b>, <b>9</b> and <b>10</b> showed low activity.</p></div